NEW YORK (GenomeWeb News) – Quidel reported after the close of the market on Wednesday that second-quarter revenues rose 12 percent year over year.

The San Diego diagnostics firm beat the consensus Wall Street estimate by posting revenues of $30.9 million for the three months ended June 30, compared to $27.5 million a year ago. Analyst estimates called for an average of $30.3 million in revenues.

R&D costs increased to $6.8 million, up 10 percent from $6.2 million a year ago, and SG&A spending was up 6 percent to $12.8 million from $12.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.